We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:0A4J | London | Ordinary Share | ASTRAZENECA ADR REPRESENTING 0.5 ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
23,500 | - |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Time | Source | Headline |
---|---|---|---|
02/1/2024 | 15:00 | UKREG | AstraZeneca PLC Total Voting Rights |
27/12/2023 | 07:00 | UKREG | AstraZeneca PLC AstraZeneca acquires Gracell |
22/12/2023 | 07:00 | UKREG | AstraZeneca PLC Wainua (eplontersen) granted first US FDA approval |
14/12/2023 | 15:00 | UKREG | AstraZeneca PLC Director/PDMR Shareholding |
12/12/2023 | 07:05 | UKREG | AstraZeneca PLC AstraZeneca to acquire Icosavax |
01/12/2023 | 15:05 | UKREG | AstraZeneca PLC Block listing Interim Review |
01/12/2023 | 15:00 | UKREG | AstraZeneca PLC Total Voting Rights |
01/12/2023 | 07:00 | UKREG | AstraZeneca PLC Discontinuation of two CRYSTALIZE evidence trials |
1 Year Astrazeneca Chart |
Intraday Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions